ATR
AptarGroup, Inc. · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 32.92K | $3.58M | n/a | −1 |
| Q2 2026 | 122 | -2 | 42.65M | $5.34B | +4 | −5 |
| Q1 2026 | 126 | -2 | 40.91M | $5.15B | +4 | −7 |
| Q4 2025 | 127 | -1 | 43.99M | $5.36B | +2 | −2 |
| Q3 2025 | 21 | +2 | 26.07M | $3.48B | +3 | −2 |
| Q2 2025 | 17 | -1 | 21.99M | $3.45B | n/a | −1 |
| Q1 2025 | 15 | +2 | 6.12M | $916.34M | +2 | n/a |
| Q4 2024 | 13 | 0 | 5.71M | $901.59M | n/a | n/a |
| Q3 2024 | 12 | 0 | 3.13M | $504.15M | n/a | n/a |
| Q2 2024 | 12 | n/a | 3.26M | $461.78M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 31.51K | +25.0% | $3.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | TD Waterhouse Canada Inc. | 1.41K | -3.9% | $170,794 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Assenagon Asset Management… | $25.02M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 538 holders, 58.90M shares, $7.20B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 765 sh · $99,733
Officer · 3.42K sh · $456,546
Officer · 325 sh · $43,730
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology